Exercise or conversion by Adam Simpson of 2395 shares of Icosavax subject to Rule 16b-3
Slightly above 67% of Icosavax's investor base is looking to short. The analysis of current outlook of investing in Icosavax suggests that many traders are alarmed regarding Icosavax's prospects. Icosavax's investing sentiment can be driven by a variety of factors including economic data, Icosavax's earnings reports, geopolitical events, and overall market trends.
Icosavax |
Filed transaction by Icosavax Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Icosavax Fundamental Analysis
We analyze Icosavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icosavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icosavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Icosavax is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Icosavax Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icosavax stock to make a market-neutral strategy. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics with similar companies.
Peers
Icosavax Related Equities
ELDN | Eledon Pharmaceuticals | 7.30 | ||||
PDSB | PDS Biotechnology | 1.87 | ||||
DAWN | Day One | 0.89 | ||||
HOOK | Hookipa Pharma | 1.11 | ||||
MREO | Mereo BioPharma | 1.78 | ||||
IMMX | Immix Biopharma | 2.57 | ||||
CNSP | Cns Pharmaceuticals | 3.51 | ||||
ABOS | Acumen Pharmaceuticals | 3.57 | ||||
AMLX | Amylyx Pharmaceuticals | 3.86 | ||||
XFOR | X4 Pharmaceuticals | 4.76 | ||||
TERN | Terns Pharmaceuticals | 6.17 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |